uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
24.71
-1.34 (-5.14%)
At close: Feb 10, 2026, 4:00 PM EST
24.78
+0.07 (0.28%)
After-hours: Feb 10, 2026, 7:03 PM EST
uniQure Market Cap
uniQure has a market cap or net worth of $1.54 billion as of February 10, 2026. Its market cap has increased by 101.52% in one year.
Market Cap
1.54B
Enterprise Value
1.38B
1-Year Change
101.52%
Ranking
Category
Stock Price
$24.71
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.54B, an increase of 855.45%. That is a compound annual growth rate of 28.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.62B | 8.86% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zymeworks | 1.68B |
| Immunocore Holdings | 1.68B |
| Enliven Therapeutics | 1.67B |
| Celldex Therapeutics | 1.65B |
| Sionna Therapeutics | 1.64B |
| Oculis Holding AG | 1.64B |
| Tyra Biosciences | 1.63B |
| Innoviva | 1.62B |